I agree that this site is using cookies. You can find further informations here.
X
Tummala, Raj
132  results:
Search for persons X
?
1

Type I interferon blockade with anifrolumab in patients wit..:

Baker, Tina ; Sharifian, Hoda ; Newcombe, Paul J...
Annals of the Rheumatic Diseases.  83 (2024)  8 - p. 1018-1027 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Correction: Targeting DORIS Remission and LLDAS in SLE: A R..:

Parra Sánchez, Agner R. ; van Vollenhoven, Ronald F. ; Morand, Eric F....
Rheumatology and Therapy.  11 (2024)  4 - p. 1059-1061 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Time to onset of clinical response to anifrolumab in patien..:

Bruce, Ian N ; van Vollenhoven, Ronald F ; Psachoulia, Konstantina...
Lupus Science & Medicine.  10 (2023)  1 - p. e000761 , 2023
Link: https://doi.org/10.1136/..
 
?
4

Clinical Pharmacokinetics, Pharmacodynamics, and Immunogeni..:

Tang, Weifeng ; Tummala, Raj ; Almquist, Joachim...
Clinical Pharmacokinetics.  62 (2023)  5 - p. 655-671 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Targeting DORIS Remission and LLDAS in SLE: A Review:

Parra Sánchez, Agner R. ; van Vollenhoven, Ronald F. ; Morand, Eric F....
Rheumatology and Therapy.  10 (2023)  6 - p. 1459-1477 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Burden of systemic lupus erythematosus in clinical practice..:

Arnaud, Laurent ; Furie, Richard ; Morand, Eric F...
Lupus Science & Medicine.  10 (2023)  2 - p. e001032 , 2023
Link: https://doi.org/10.1136/..
 
?
7

Lupus low disease activity state attainment in the phase 3 ..:

Morand, Eric F ; Abreu, Gabriel ; Furie, Richard A..
Annals of the Rheumatic Diseases.  82 (2023)  5 - p. 639-645 , 2023
Link: https://doi.org/10.1136/..
 
?
8

Anifrolumab in lupus nephritis: results from second-year ex..:

Jayne, David ; Rovin, Brad ; Mysler, Eduardo...
Lupus Science & Medicine.  10 (2023)  2 - p. e000910 , 2023
Link: https://doi.org/10.1136/..
 
?
9

Impact of SARS-CoV-2 infection on patients with systemic lu..:

Rabe, Adrian Paul J ; Loke, Wei Jie ; Kalyani, Rubana N...
BMJ Open.  13 (2023)  11 - p. e071072 , 2023
Link: https://doi.org/10.1136/..
 
?
10

Efficacy of anifrolumab across organ domains in patients wi..:

Morand, Eric F ; Furie, Richard A ; Bruce, Ian N...
The Lancet Rheumatology.  4 (2022)  4 - p. e282-e292 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Anifrolumab efficacy and safety by type I interferon gene s..:

Vital, Edward M ; Merrill, Joan T ; Morand, Eric F...
Annals of the Rheumatic Diseases.  81 (2022)  7 - p. 951-961 , 2022
Link: https://doi.org/10.1136/..
 
?
12

Relationship Between Anifrolumab Pharmacokinetics, Pharmaco..:

Chia, Yen Lin ; Tummala, Raj ; Mai, Tu H....
The Journal of Clinical Pharmacology.  62 (2022)  9 - p. 1094-1105 , 2022
Link: https://doi.org/10.1002/..
 
?
13

A Randomized, Placebo‐Controlled Phase III Extension Trial ..:

Kalunian, Kenneth C. ; Furie, Richard ; Morand, Eric F....
Arthritis & Rheumatology.  75 (2022)  2 - p. 253-265 , 2022
Link: https://doi.org/10.1002/..
 
?
14

Causal cascade of direct and indirect effects of anifroluma..:

Stull, Donald ; O'Quinn, Sean ; Williams, Betsy...
Rheumatology.  61 (2022)  12 - p. 4731-4740 , 2022
Link: https://doi.org/10.1093/..
 
?
15

Phase II randomised trial of type I interferon inhibitor an..:

Jayne, David ; Rovin, Brad ; Mysler, Eduardo F...
Annals of the Rheumatic Diseases.  81 (2022)  4 - p. 496-506 , 2022
Link: https://doi.org/10.1136/..
 
1-15